B. Riley Securities Initiates Coverage On Strata Critical Medical with Buy Rating, Announces Price Target of $8

B. Riley Securities has initiated coverage on Strata Critical Medical (NASDAQ: SRTA) with a Buy rating. The analyst, Yuan Zhi, has set a price target of $8 for the company's stock.